BioVaxys Technology Corp.
BioVaxys Technology Corp.
BioVaxys Technology Corp. is a British Columbia-registered biopharmaceuticals company based in Ontario, Canada that is developing BVX-0918, a personalized immunotherapeutic vaccine using our proprietary HapTenix© 'neoantigen' tumor cell construct platform for treating refractive late stage ovarian cancer. BioVaxys is also exploring vaccines for additional cancers and infectious diseases based on its HapTenix©platform through academic and other collaborations.
BioVaxys Technology Corp. (BIOV)
BioVaxys Technology Corp. (BIOV)
*Note: Bid Size and Ask Size fields are displayed as actual quantities
*Note: Bid Size and Ask Size fields are displayed as actual quantities
*Note: Bid Size and Ask Size fields are displayed as actual quantities
*Note: Bid Size and Ask Size fields are displayed as actual quantities
Bid Broker | Bid Size | Bid Price | Ask Price | Ask Size | Ask Broker |
---|---|---|---|---|---|
TD Securities Inc. | 2,000 | 0.05 | 0.055 | 68,000 | Anonymous |
Anonymous | 12,000 | 0.05 | 0.055 | 3,000 | TD Securities Inc. |
Anonymous | 4,000 | 0.05 | 0.06 | 10,000 | TD Securities Inc. |
CIBC World Markets Inc. | 50,000 | 0.045 | 0.06 | 60,000 | CIBC World Markets Inc. |
CIBC World Markets Inc. | 100,000 | 0.045 | 0.06 | 1,000 | National Bank Financial Inc. |
W.D. Latimer Co. Limited | 10,000 | 0.045 | 0.06 | 1,000 | National Bank Financial Inc. |
National Bank Financial Inc. | 11,000 | 0.045 | 0.06 | 1,000 | National Bank Financial Inc. |
TD Securities Inc. | 2,000 | 0.045 | 0.06 | 26,000 | National Bank Financial Inc. |
TD Securities Inc. | 20,000 | 0.045 | 0.065 | 4,000 | National Bank Financial Inc. |
National Bank Financial Inc. | 4,000 | 0.045 | 0.065 | 80,000 | Aviso Financial Inc. |
Bid Broker | Bid Size | Bid Price | Ask Price | Ask Size | Ask Broker |
---|---|---|---|---|---|
Anonymous | 20,000 | 0.04 | 0.00 | 0 | |
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 |
Bid Count | Bid Size | Bid Price | Ask Price | Ask Size | Ask Count |
---|---|---|---|---|---|
3 | 18,000 | 0.05 | 0.055 | 71,000 | 2 |
7 | 197,000 | 0.045 | 0.06 | 99,000 | 6 |
10 | 255,000 | 0.04 | 0.065 | 156,000 | 16 |
6 | 110,000 | 0.035 | 0.07 | 298,000 | 8 |
2 | 75,000 | 0.03 | 0.075 | 2,105,000 | 4 |
Bid Count | Bid Size | Bid Price | Ask Price | Ask Size | Ask Count |
---|---|---|---|---|---|
1 | 20,000 | 0.04 | 0.00 | 0 | 0 |
0 | 0 | 0.00 | 0.00 | 0 | 0 |
0 | 0 | 0.00 | 0.00 | 0 | 0 |
0 | 0 | 0.00 | 0.00 | 0 | 0 |
0 | 0 | 0.00 | 0.00 | 0 | 0 |
Date/Time | Price | Change | Volume | Buyer | Seller | Venue |
---|---|---|---|---|---|---|
Mar 19, 16:34 | 0.055 | 0.005 | 4,000 | National Bank Financial Inc. | Anonymous | CSE |
Mar 19, 15:38 | 0.055 | 0.005 | 2,000 | National Bank Financial Inc. | National Bank Financial Inc. | CSE |
Mar 19, 15:38 | 0.055 | 0.005 | 3,000 | National Bank Financial Inc. | Anonymous | CSE |
Mar 18, 19:38 | 0.05 | 0.00 | 3,000 | Anonymous | Anonymous | CSE |
Mar 18, 19:38 | 0.05 | 0.00 | 2,000 | TD Securities Inc. | Anonymous | CSE |
Company Info
SEDAR Information
Company Info
Capitalization
Company Officers
News Releases
Bulletins
2024-0715 - Reinstatement - BioVaxys Technology Corp. (BIOV)
le 16 juillet/July 2024
Effective immediately, BioVaxys Technology Corp. will be reinstated for trading.
The Company has rectified the situation that gave rise to the suspension.
____________________________
Avec effet immédiat, BioVaxys Technology Corp. sera réintégrée à la négociation.
La Société a rectifié la situation qui a donné lieu à la suspension.